Analysis of loss of heterozygosity in Korean patients with keratoacanthoma

Journal of Korean Medical Science

Volumn 20, Issue 2, 2005, Pages 340-343

  Ha, Tae Won ^a   Han, Ki Hwan ^a   Son, Dae Gu ^a   Kim, Sang Pyo ^a   Kim, Dae Kwang ^b  

^a Keimyung University   (South Korea)

^b Keimyung University School of Medicine   (South Korea)

Author keywords

Keratoacanthoma; Loss of Heterozygosity

Indexed keywords

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE LOCUS; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KERATOACANTHOMA; MALE; MICROSATELLITE MARKER; POLYMERASE CHAIN REACTION;

EID: 18244409867     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2005.20.2.340     Document Type: Article

References (26)

1. Kern WH, McCray MK. The histopathologic differentiation of keratoacanthoma and squamous cell carcinoma of the skin. J Cutan Pathol 1980; 7: 318-25.
2. Schwartz RA. Keratoacanthoma. J Am Acad Dermatol 1994; 30: 1-19.
3. Sanders GH, Miller TA. Are kearatoacanthomas really squamous cell carcinomas? Ann Plast Surg 1982; 9: 306-9.
4. Requena L, Romero E, Sanchez M, Ambrojo P, Sanchez Yus E. Aggressive keratoacanthoma of the eyelid: "malignant" keratoacanthoma or squamous cell carcinoma? J Dermatol Surg Oncol 1990; 16: 564-8.
5. Hodak E, Jones RE, Ackerman AB. Solitary keratoacanthoma is a squamous cell carcinoma: three examples with metastases. Am J Dermatopathol 1993; 15: 332-42.
6. Fearon ER. Human cancer syndromes: clues to the origin nature of cancer. Science 1997; 278: 1043-50.
7. Mao LI, Fan YH, Lotan R, Hong WK. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. Cancer Res 1996; 56: 5128-31.
8. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67.
9. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W, Sidransky D. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996; 56: 2488-92.
10. Peris K, Magrini F, Keller G, Manente L, D'Alessandro E, Onorati MT, Hofler H, Chimenti S. Analysis of microsatellite instability and loss of heterozygosity in keratoacanthoma. Arch Dermatol Res 1997; 289: 185-8.
11. Langenbach N, Kroiss MM, Rüschoff J, Schlegel J, Landthaler M, Stolz W. Assessment of microsatellite instability and loss of heterozygosity in sporadic keratoacanthomas. Arch Dermatol Res 1999; 291: 1-5.
12. Waring AJ, Takata M, Rehman I, Rees JL. Loss of heterozygosity analysis of keratoacanthoma reveals multiple differences from cutaneous squamous cell carcinoma. Br J Cancer 1996; 73: 649-53.
13. Kim DK, Kim JY, Kim HT, Han KH, Shon DG. A specific chromosome aberration in a keratoacanthoma. Cancer Genet Cytogenet 2003; 142: 70-2.
14. Akalu A, Reichardt JK. A reliable PCR amplification method for microdissected tumor cells obtained from paraffin-embedded tissue. Genet Anal 1999; 15: 229-33.
15. Sepp T, Yates JR, Green AJ. Loss of heterozygosity in tuberous sclerosis hamartomas. J Med Genet 1996; 33: 962-4.
16. Matt D, Xin H, Vortmeyer AO, Zhuang Z, Burg G, Böni R. Sporadic trichoepithelioma demonstrates deletions at 9q22.3. Arch Dermatol 2000; 136: 657-60.
17. Verhoef S, Schrander-Stumpel CT, Vuzevski VD, Tempelaars A, Jansen LA, Malfeyt GA, Ceelen TL, Lindhout D, Halley DJ, van den Ouweland AM. Familial cylindromatosis mimicking tuberous sclerosis complex and confirmation of the cylindromatosis locus, CYLD1, in a large family. J Med Genet 1998; 35: 841-5.
18. Böni R, Zhuang Z, Albuquerque A, Vortmeyer A, Duray P. Loss of heterozygosity detected on 1p and 9q in microdissected atypical nevi. Arch Dermatol 1998; 134: 882-3.
19. Pack S, Turner ML, Zhuang Z, Vortmeyer AO, Boni R, Skarulis M, Marx SJ, Darling TN. Cutaneous tumors in patients with multiple endocrine neoplasia type 1 show allelic deletion of the MEN1 gene. J Invest Dermatol 1998; 110: 438-40.
20. Colman SD, Williams CA, Wallace MR. Benign neurofibromas in type1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene. Nat Genet 1995; 11: 90-2.
21. Mertens F, Heim S, Mandahl N, Johansson B, Rydholm A, Biorklund A, Wennerberg J, Jonsson N, Mitelman F. Clonal chromosome aberrations in a keratoacanthoma and a basal cell papilloma. Cancer Genet Cytogenet 1989; 39: 227-32.
22. Schwartz RA, Torre DP. The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol 1995; 33: 90-104.
23. Rehman I, Quinn AG, Healy E, Rees JL. High frequency of loss of heterozygosity in actinic keratoses, a usually benign disease. Lancet 1994; 344: 788-9.
24. Borkowski A, Bennett WP, Jones RT, Borkowski P, Harris CC, Ferreira LR, Kao GF, Trump BF. Quantitative image analysis of p53 protein accumulation in keratoacanthomas. Am J Dermatopathol 1995; 17: 335-8.
25. Perez MI, Robins P, Biria S, Roco J, Siegel E, Pellicer A. P53 oncoprotein expression and gene mutations in some keratoacanthomas. Arch Dermatol 1997; 133: 189-93.
26. Clausen OP, Beigi M, Bolund L, Kølvraa S, Gjersvik PJ, Mork G, de Angelis PM. Keratoacanthomas frequently show chromosomal aberrations as assessed by comparative genomic hybridization. J Invest Dermatol 2002; 119: 1367-72.